Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Dec 15;289(6459):1651–1653. doi: 10.1136/bmj.289.6459.1651

How soon after myocardial infarction should plasma lipid values be assessed?

R E Ryder, T M Hayes, I P Mulligan, J C Kingswood, S Williams, D R Owens
PMCID: PMC1443809  PMID: 6439361

Abstract

Because acute myocardial infarction may affect plasma lipid concentrations it is commonly recommended that assessment of these concentrations should be delayed until about three months after the acute event. A study was therefore conducted of fasting plasma lipid concentrations in 58 patients with acute myocardial infarction. Measurements were made during their stay in hospital (days 1, 2, and 9) and three months later. Triglyceride concentrations remained unchanged throughout. Values of total cholesterol, low density lipoprotein, and high density lipoprotein all fell significantly between the first two days and day 9. Total cholesterol and low density lipoprotein also showed significant falls between days 1 and 2. Nevertheless, fasting plasma lipid concentrations showed no significant difference at any time during the first 48 hours from values measured three months later. After the infarction 26 patients changed to eating less fat or less energy, or both. More patients had hypercholesterolaemia in the first 48 hours than at three months. These results suggest that lipid state may be assessed as accurately, and possibly more accurately, during the first 48 hours after acute myocardial infarction than at three months.

Full text

PDF
1651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avogaro P., Bon G. B., Cazzolato G., Quinci G. B., Sanson A., Sparla M., Zagatti G. C., Caturelli G. Variations in apolipoproteins B and A1 during the course of myocardial infarction. Eur J Clin Invest. 1978 Jun;8(3):121–129. doi: 10.1111/j.1365-2362.1978.tb00824.x. [DOI] [PubMed] [Google Scholar]
  2. BIORCK G., BLOMQVIST G., SIEVERS J. Cholesterol values in patients with myocardial infarction and in a normal control group. Acta Med Scand. 1957 Feb 2;156(6):493–497. doi: 10.1111/j.0954-6820.1957.tb00107.x. [DOI] [PubMed] [Google Scholar]
  3. Ballantyne F. C., Melville D. A., McKenna J. P., Morrison B. A., Ballantyne D. Response of plasma lipoproteins and acute phase proteins to myocardial infarction. Clin Chim Acta. 1979 Nov 15;99(1):85–92. doi: 10.1016/0009-8981(79)90142-6. [DOI] [PubMed] [Google Scholar]
  4. Buckley B. M., Bold A. M. Managing hyperlipidaemias. Br Med J (Clin Res Ed) 1982 Nov 6;285(6351):1293–1294. doi: 10.1136/bmj.285.6351.1293. [DOI] [PubMed] [Google Scholar]
  5. DODDS C., MILLS G. L. Influence of myocardial infarction on plasma-lipoprotein concentration. Lancet. 1959 Jun 6;1(7084):1160–1163. doi: 10.1016/s0140-6736(59)91178-x. [DOI] [PubMed] [Google Scholar]
  6. Fyfe T., Baxter R. H., Cochran K. M., Booth E. M. Plasma-lipid changes after myocardial infarction. Lancet. 1971 Nov;2(7732):997–1001. doi: 10.1016/s0140-6736(71)90322-9. [DOI] [PubMed] [Google Scholar]
  7. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  8. Heldenberg D., Rubinstein A., Levtov O., Berns L., Werbin B., Tamir I. Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction. Atherosclerosis. 1980 Apr;35(4):433–437. doi: 10.1016/0021-9150(80)90184-7. [DOI] [PubMed] [Google Scholar]
  9. Keys A., Aravanis C., Blackburn H., Van Buchem F. S., Buzina R., Djordjevic B. S., Fidanza F., Karvonen M. J., Menotti A., Puddu V. Probability of middle-aged men developing coronary heart disease in five years. Circulation. 1972 Apr;45(4):815–828. doi: 10.1161/01.cir.45.4.815. [DOI] [PubMed] [Google Scholar]
  10. Kirkeby K. Disturbances in serum lipids and in their fatty acid composition following acute myocardial infarction. Acta Med Scand. 1972 Dec;192(6):523–528. doi: 10.1111/j.0954-6820.1972.tb04860.x. [DOI] [PubMed] [Google Scholar]
  11. Rosenhamer G., Carlson L. A. Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease. Atherosclerosis. 1980 Sep;37(1):129–142. doi: 10.1016/0021-9150(80)90100-8. [DOI] [PubMed] [Google Scholar]
  12. TIBBLIN G., CRAMER K. SERUM LIPIDS DURING THE COURSE OF AN ACUTE MYOCARDIAL INFARCTION AND ONE YEAR AFTERWARDS. Acta Med Scand. 1963 Oct;174:451–455. doi: 10.1111/j.0954-6820.1963.tb07944.x. [DOI] [PubMed] [Google Scholar]
  13. Takahashi M., Sasayama S., Kawai C., Kotoura H. Contractile performance of the hypertrophied ventricle in patients with systemic hypertension. Circulation. 1980 Jul;62(1):116–126. doi: 10.1161/01.cir.62.1.116. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES